Identification of Biomarkers Associated with Cancerous Change in Oral Leukoplakia Based on Integrated Transcriptome Analysis

Table 3

Binding energy of molecular docking.

No.	Receptor	Ligand	Minimum (kcal/mol)	The average of the first five smallest values (kcal/mol)	Average of all minimums (kcal/mol)
vina1	DCT	Selumetinib	−5.7	−5.24	−5.03333
vina2	DCT	Benidipine	−8.2	−6.56	−5.95556
vina3	DCT	Levetiracetam	−5	−4.58	−4.25556
vina4	DCT	Ampicillin	−5.5	−5.46	−5.4
vina5	DCT	Aminolevulinic acid	−5.1	−4.7	−4.54444
vina6	KRT3	Selumetinib	−4.8	−4.46	−4.31111
vina7	KRT3	Benidipine	−4.8	−4.46	−4.3
vina8	KRT3	Levetiracetam	−3.5	−3.28	−3.15556
vina9	KRT3	Ampicillin	−4.8	−4.6	−4.53333
vina10	KRT3	Aminolevulinic-acid	−2.9	−2.86	−2.76667
vina11	KRT76	Selumetinib	−4.6	−4.44	−4.34444
vina12	KRT76	Benidipine	−4.6	−4.5	−4.38889
vina13	KRT76	Levetiracetam	−3.4	−3.12	−2.91111
vina14	KRT76	Ampicillin	−4.4	−4.12	−4.05556
vina15	KRT76	Aminolevulinic acid	−3	−2.78	−2.68889
vina16	FAM3B	Selumetinib	−5.6	−5.3	−5.11111
vina17	FAM3B	Benidipine	−6	−5.68	−5.44444
vina18	FAM3B	Levetiracetam	−4.4	−4.02	−3.73333
vina19	FAM3B	Ampicillin	−5.8	−5.48	−5.33333
vina20	FAM3B	Aminolevulinic acid	−3.8	−3.72	−3.54444